The outcome of orlistat in individuals with hepatic and/or renal impairment has not orlos (orlistat 60mg) been examined (see area 4.4). having said that, as orlistat is minimally absorbed, no dose adjustment is necessary in individuals with hepatic and/or renal impairment. clients need to accomplish at least a 5% reduction of their General bodywei